Advocating for a cure for Herpes Simplex Virus.
Join Dr. TJ Cradick, Chief Scientific Officer at Excision Biotherapeutics to learn about Excision Bio pre-clinical work in gene therapy for Herpes Simplex. Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients. A recognized expert in genome editing technologies, Dr. Cradick has developed nucleases, as wellContinue reading "Dr. TJ Cradick: Excision Biotherapeutics"
Professor, Vaccine and Infectious Disease Division Dr. Keith Jerome is a renowned virologist whose research focuses on viruses such as herpes simplex, HIV and hepatitis B that persist in their hosts. He studies the ways in which these viruses evade the immune system and potential therapies for these infections. Dr. Jerome and The Jerome LabContinue reading "Dr. Keith Jerome: Fred Hutch Cancer Center"
Professor and Vice Chair for Research, Department of Pediatrics and Microbiology-Immunology. Chief, Division of Pediatric Infectious Diseases Albert Einstein College of Medicine Betsy Herold, M.D. directs a basic and translational research program, which focuses on the prevention of HIV and HSV and other viral infections. Basic research in the lab focuses on the development ofContinue reading "Betsy C. Herold, M.D.: Harold and Muriel Block Chair, Dept. of Pediatrics"
Join for a discussion with Herpes Cure Advocacy medical advisory board member Dr. Gary Richwald. Learn about the latest advances in herpes simplex virus cure, treatment and prevention efforts in the US and globally, how to advocate for change, the role of the patient advocate and more.
Herpes Cure Advocacy Meet the Experts series returns this Fall with Dr. Anna Wald and an overview of the clinical pipeline for Herpes. Dr Anna Wald is Professor in the Department of Medicine, Epidemiology and Laboratory Medicine & Pathology at the University of Washington and in the Vaccine and Infectious Diseases Division at the Fred HutchinsonContinue reading "Highlights from the Herpes Cure Pipeline 3.0 w/ Dr. Anna Wald"
Dr. Christine Johnston will give us an update on genital HSV-1 infections including results from a recent large study of the natural history of genital HSV-1 infection. She will discuss what we still need to learn about HSV-1 infections. For more information and how to register, click here.
Terri Warren will present some of the preliminary data from the herpes survey. Make sure to bring your questions, as there will be a q&a after. For more info about TerriContinue reading "Terri Warren Talk with Q&A"
Learn more about the exciting and fast developing field of vaccines for Herpes Simplex Virus. View Recorded Talk. AGENDA: Welcome Herpes Vaccines Herpes Cure Pipeline LOCATION: CDC STI Prevention ConferenceContinue reading "Herpes Cure Pipeline: New Drugs and Vaccines on the Horizon"
Guest Speaker: Dr. Carolyn Deal NIAID/NIH STI Section Chief The National Institutes of Health (NIH) released a strategic plan for herpes simplex virus (HSV) research in September 2023. The plan’s goals are to improve understanding of HSV, develop better diagnostics, and improve treatments and prevention strategies. The plan’s four strategic priorities are: Prevent infection: AdvanceContinue reading "HVTN Partnership: Presentation on the NIH/NIAID Strategic Research Plan for Herpes Simplex Virus"
Guest Speaker: Dr. Akiko Iwasaki, Ph.D Akiko Iwasaki, PhD, a professor of immunobiology at Yale School of Medicine and an investigator of the Howard Hughes Medical Institute, turned her focus to SARS-CoV-2 soon after reading the first reports coming out of China, before COVID-19 surfaced in the United States. Though she has long been recognized forContinue reading "HVTN Partnership: Vaccinology of HSV"
Guest Speaker: Dr. Ruth Itzhaki Professor Ruth Itzhaki is a Visiting Professorial Fellow at the Oxford Institute of Population Ageing. Professor Itzhaki is a research scientist. She graduated as a physicist, then carried out research for an MSc and PhD in Biophysics – all London University degrees. She subsequently moved to Cambridge, to the DepartmentContinue reading "HVTN Partnership: HSV Association with Alzheimer’s Disease"
Please join us December 5th for a special presentation on HSV Vaccines and what is in the pipeline! Dr. Simon Delagrave Simon is a life sciences R&D executive, consultant, and board member whose 28 years of professional experience span infectious diseases and gene therapy, deploying various technologies such as viral vectors, vaccines, antibodies, structural biology,Continue reading "Dr. Simon Delagrave: The HSV Vaccine Pipeline Needs New Ideas – a More Technical Discussion of HSV Vaccinology"